Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples